Decentralization began as a shared conviction — a belief that the world could be rebuilt on principles of openness, transparency, and trustless collaboration. What started as a movement among a passionate few has evolved into a global force, laying the groundwork for a new kind of infrastructure — one that transcends borders, intermediaries, and outdated systems. Nowhere is this transformation more visible than in finance, where blockchain-based systems are being adopted by traditional institutions at an unprecedented pace. The tokenization of Real World Assets (RWAs) is leading this shift, serving as a bridge between legacy finance and the programmable, composable infrastructure of tomorrow. The momentum is undeniable. We believe that soon, the distinction between “traditional” and “onchain” finance will disappear. There will be just one finance — open by design, powered by cryptographic systems, and governed by principles that have quietly become the standard.
A new era for finance, then.
But also — a new era for Enzyme.
Founded in 2017, Enzyme was built on the early recognition that digital asset management would require secure, flexible, and programmable systems. What began as a protocol tailored to hedge fund managers has evolved into a leading platform — praised for its versatility, security, composability, and seamless user experience.
From tokenized funds and liquidity pools to on-chain financial instruments like ETPs and indices, Enzyme Vaults have become a powerful building block for tokenized finance.
But in this great convergence, something has been missing — a force to connect the dots, to drive performance, adoption, and scale. Enzyme is that force. And no one is better positioned to accelerate the adoption of decentralized solutions — and the ethos that underpins them.
A global infrastructure for tokenized finance
Today, we are proud to announce a pivotal evolution: Enzyme is becoming a global infrastructure for tokenized finance.
With this strategic shift, Enzyme is committed to empowering industry leaders with end-to-end solutions to manage onchain assets, streamline operations, and build innovative financial strategies tailored to their unique goals.
At the heart of this infrastructure lies our Vault-as-a-Service offering, with complementary product lines including:
- Enzyme.Blue – our newly rebranded historical platform. Enzyme.Blue enables businesses and institutions to launch and manage tokenized funds, liquidity pools, and onchain financial products — with unparalleled flexibility and control, all within a unified environment.
- Enzyme.Onyx – a wallet-tokenization layer powered by our proprietary architecture. Enzyme.Onyx introduces the concept of tokenized wallets, unlocking unrestricted, modular digital asset management across the board.
As part of its infrastructure, Enzyme also offers advanced financial instrument solutions. Enzyme.Myso is our premier options protocol, purpose-built for institutional-grade portfolio management. It enables users to execute strategies like covered calls and cash-secured puts with just a few clicks — automated or over-the-counter, and on-chain.
Together, these offerings form a global infrastructure built to support every stage of the onchain finance journey for businesses and institutions embracing decentralized solutions — from portfolio construction and trade execution to operations, risk management, and analytics. And this is just the beginning. This evolution continues the trajectory we began last year, through the acquisition of Myso Finance and our strategic investment in Neutral Trade — with more to come.
Over the next month, we’ll be unveiling more about our infrastructure, how it can help institutions and innovators scale their ambitions, and what lies ahead for Enzyme.
Together, let’s ignite the future of finance.
